Clinical trial NCT06392958: Application of Improved Baduanjin Combined Cross-theoretical Model Based on Internet in Family Empowering Elderly PCI Cardiac Rehabilitation
Official title: Application of Improved Baduanjin Combined Cross-theoretical Model Based on Internet in Family Empowering Elderly PCI Cardiac Rehabilitation
Study type: INTERVENTIONAL
Overall status: RECRUITING
Phase: NA
Conditions: Coronary Heart Disease
Keywords: Coronary heart disease
ba duan jin
Cross-theoretical model
Family empowerment
Lead sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Sponsor class: OTHER
First posted: 2024-05-01
Enrollment: 120
Sex: ALL
Minimum age (years): 60
Maximum age (years): 75
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: SINGLE_GROUP
Primary purpose: OTHER

Brief summary: This study explores the effect of Internet based improved Baduanjin combined cross-theoretical model in family empowering cardiac rehabilitation for elderly patients with coronary heart disease after PCI, provides a scientific and reasonable case management plan for the rehabilitation of patients with coronary heart disease, and provides a reference for the development of scientific and refined cardiac rehabilitation case management suitable for elderly patients with PCI.

Detailed description: In this study, a total of 120 elderly patients with coronary heart disease who underwent PCI in our hospital from July 2024 to July 2025 were selected, and an improved Baduanjin combined cross-theoretical model based on the Internet was applied to empower family cardiac rehabilitation management. The effect of this method on cardiac rehabilitation of elderly patients with coronary heart disease after PCI operation was evaluated by four indexes: cardiac function index, quality of life, medication compliance and satisfaction degree, and scientific guidance was provided for clinical cardiac rehabilitation practice.

Eligibility criteria: Inclusion Criteria:

* (1) All met the diagnostic criteria for coronary heart disease;
* (2) PCI was performed for the first time with clear indications of PCI surgery;
* (3) Postoperative condition was stable;
* (4) NYHA cardiac function grade I-II;
* (5) Age 60 \~75 years old;
* (6) Patients and their family members gave informed consent to this study and signed informed consent, which met the ethical standards of human trials and was approved by the ethics committee of the hospital.

Exclusion Criteria:

* (1) Uncontrolled arrhythmias combined with hemodynamic abnormalities.
* (2) COPD, pulmonary embolism, deep vein thrombosis, stroke and other factors affecting motor function.
* (3) Physical disability affecting safety and full participation in the experiment.
* (4) myocarditis, cardiomyopathy, liver and kidney insufficiency.
* (5) Aphasia, hearing impairment and other conditions affecting normal doctor-patient communication.

Primary outcomes:
measure: left ventricular Ejection fraction (LVEF)
timeFrame: base line and 6 months after intervention
Secondary outcomes:
measure: Quality of life of patients after PCI
timeFrame: base line and 6 months after intervention
measure: Medication compliance
timeFrame: base line and 6 months after intervention
measure: The evaluation results of patient satisfaction at 6 months after intervention were compared between the groups
timeFrame: base line and 6 months after intervention
Other outcomes:
Locations:
city: Yiwu
country: China
facility: The Fourth Affiliated Hospital of Zhejiang University School of Medicine
state: Zhejiang
Study officials:
affiliation: 4th Affiliated Hospital, School of Medicine, Zhejiang University, China
name: Shanshan Si, BA
role: PRINCIPAL_INVESTIGATOR
References: